BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/8/2025 9:47:32 AM | Browse: 31 | Download: 0
Publication Name World Journal of Hepatology
Manuscript ID 107705
Country China
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Pathogenesis and clinical management of liver damage in porphyrias: Mechanisms and therapeutic approaches
Manuscript Source Invited Manuscript
All Author List Tao Zeng, Shu-Ying Huang, Jian-Ning Chen, Jia-Hui Pang, Yu-Tian Chong and Xin-Hua Li
Funding Agency and Grant Number
Corresponding Author Xin-Hua Li, Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road, Guangzhou 510630, Guangdong Province, China, Guangzhou 510630, Guangdong Province, China. lixinh8@mail.sysu.edu.cn
Key Words Porphyria; Porphyria-related liver injury; Pathophysiology; Hepatic cutaneous porphyrias; Protoporphyria; Acute hepatic porphyrias
Core Tip Porphyria-related liver injury, driven by toxic accumulation of heme biosynthesis intermediates, presents diagnostic challenges due to nonspecific symptoms and insidious progression. The "Two-Hit Model" (porphyrin-protein aggregation and oxidative stress) underpins hepatotoxicity, while protoporphyria-associated cholestasis, liver failure, and acute hepatic porphyria-linked hepatocellular carcinoma (HCC) further increase morbidity. Diagnosis follows a multistep process integrating biochemical profiling, histopathological examination, and genetic testing. Current therapies are palliative, whereas emerging approaches—such as RNA interference (givosiran), melanocortin agonists (afamelanotide), and gene-editing technologies—provide mechanistic targeting. Early surveillance for HCC and multidisciplinary management are essential to mitigate life-threatening complications in these rare metabolic disorders.
Citation Zeng T, Huang SY, Chen JN, Pang JH, Chong YT, Li XH. Pathogenesis and clinical management of liver damage in porphyrias: Mechanisms and therapeutic approaches. World J Hepatol 2025; In press
Received
2025-04-01 13:36
Peer-Review Started
2025-04-01 13:37
To Make the First Decision
Return for Revision
2025-05-03 16:04
Revised
2025-05-16 12:34
Second Decision
2025-08-07 02:44
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-08-08 09:47
Articles in Press
2025-08-08 09:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com